Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity.

Belujon P, Grace AA.

Biol Psychiatry. 2014 Dec 15;76(12):927-36. doi: 10.1016/j.biopsych.2014.04.014. Epub 2014 May 6.

PMID:
24931705
[PubMed - in process]
2.

Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway.

Valenti O, Grace AA.

Int J Neuropsychopharmacol. 2010 Aug;13(7):845-60. doi: 10.1017/S1461145709990599. Epub 2009 Sep 15.

PMID:
19751544
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway.

Kamiyama H, Matsumoto M, Otani S, Kimura SI, Shimamura KI, Ishikawa S, Yanagawa Y, Togashi H.

Neuroscience. 2011 Mar 17;177:159-69. doi: 10.1016/j.neuroscience.2010.12.012. Epub 2010 Dec 14.

PMID:
21163337
[PubMed - indexed for MEDLINE]
4.

Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression.

Lemon N, Manahan-Vaughan D.

J Neurosci. 2006 Jul 19;26(29):7723-9.

PMID:
16855100
[PubMed - indexed for MEDLINE]
Free Article
5.

Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats.

Hunt MJ, Kessal K, Garcia R.

J Neurosci. 2005 Jan 12;25(2):524-31.

PMID:
15647498
[PubMed - indexed for MEDLINE]
Free Article
6.

Synaptic mechanisms underlying rapid antidepressant action of ketamine.

Kavalali ET, Monteggia LM.

Am J Psychiatry. 2012 Nov;169(11):1150-6. Review.

PMID:
23534055
[PubMed - indexed for MEDLINE]
7.

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.

Naughton M, Clarke G, O'Leary OF, Cryan JF, Dinan TG.

J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10. Review.

PMID:
24388038
[PubMed - indexed for MEDLINE]
8.

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants.

Browne CA, Lucki I.

Front Pharmacol. 2013 Dec 27;4:161. doi: 10.3389/fphar.2013.00161. Review.

PMID:
24409146
[PubMed]
Free PMC Article
9.

Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.

Koike H, Iijima M, Chaki S.

Behav Brain Res. 2011 Oct 10;224(1):107-11. doi: 10.1016/j.bbr.2011.05.035. Epub 2011 Jun 6.

PMID:
21669235
[PubMed - indexed for MEDLINE]
10.

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM.

Nature. 2011 Jun 15;475(7354):91-5. doi: 10.1038/nature10130.

PMID:
21677641
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Monoamine neurocircuitry in depression and strategies for new treatments.

Hamon M, Blier P.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:54-63. doi: 10.1016/j.pnpbp.2013.04.009. Epub 2013 Apr 19. Review.

PMID:
23602950
[PubMed - indexed for MEDLINE]
12.

[Ketamine's antidepressant effect: focus on ketamine mechanisms of action].

De Maricourt P, Jay T, Goncalvès P, Lôo H, Gaillard R.

Encephale. 2014 Feb;40(1):48-55. doi: 10.1016/j.encep.2013.09.002. Epub 2014 Jan 13. Review. French.

PMID:
24434007
[PubMed - indexed for MEDLINE]
13.

Dopamine receptors and learned helplessness in the rat: an autoradiographic study.

Kram ML, Kramer GL, Ronan PJ, Steciuk M, Petty F.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):639-45.

PMID:
12188094
[PubMed - indexed for MEDLINE]
14.

GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Burgdorf J, Zhang XL, Nicholson KL, Balster RL, Leander JD, Stanton PK, Gross AL, Kroes RA, Moskal JR.

Neuropsychopharmacology. 2013 Apr;38(5):729-42. doi: 10.1038/npp.2012.246. Epub 2012 Dec 5.

PMID:
23303054
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
[PubMed - indexed for MEDLINE]
16.

The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.

Monteggia LM, Gideons E, Kavalali ET.

Biol Psychiatry. 2013 Jun 15;73(12):1199-203. doi: 10.1016/j.biopsych.2012.09.006. Epub 2012 Oct 11. Review.

PMID:
23062356
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.

Cornwell BR, Salvadore G, Furey M, Marquardt CA, Brutsche NE, Grillon C, Zarate CA Jr.

Biol Psychiatry. 2012 Oct 1;72(7):555-61. doi: 10.1016/j.biopsych.2012.03.029. Epub 2012 Apr 21.

PMID:
22521148
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors.

Duan TT, Tan JW, Yuan Q, Cao J, Zhou QX, Xu L.

Psychopharmacology (Berl). 2013 Aug;228(3):451-61. doi: 10.1007/s00213-013-3048-2. Epub 2013 Mar 14.

PMID:
23494232
[PubMed - indexed for MEDLINE]
19.

Nicotine potentiation of excitatory inputs to ventral tegmental area dopamine neurons.

Mao D, Gallagher K, McGehee DS.

J Neurosci. 2011 May 4;31(18):6710-20. doi: 10.1523/JNEUROSCI.5671-10.2011.

PMID:
21543600
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk